JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥13,196,000 | ¥18,756,000 | ¥13,278,000 | ¥30,733,000 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥244,000 |
| Receivables | ¥12,236,000 | ¥14,934,000 | ¥11,137,000 | ¥15,585,000 |
| Inventory | ¥21,758,000 | ¥20,933,000 | ¥18,514,000 | ¥14,636,000 |
| Other Curr. Assets | ¥3,866,000 | ¥2,958,000 | ¥4,873,000 | ¥990,000 |
| Total Curr. Assets | ¥51,056,000 | ¥57,581,000 | ¥47,802,000 | ¥62,188,000 |
| Property Plant & Equip (Net) | ¥37,410,000 | ¥30,040,000 | ¥32,681,000 | ¥26,782,000 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥2,960,000 | ¥3,496,000 | ¥3,652,000 | ¥2,960,000 |
| Long-Term Investments | ¥9,629,000 | ¥9,120,000 | ¥8,867,000 | ¥2,230,000 |
| Tax Assets | ¥2,985,000 | ¥0 | ¥1,357,000 | ¥2,433,000 |
| Other NC Assets | ¥815,000 | ¥1,989,000 | ¥576,000 | ¥539,000 |
| Total NC Assets | ¥53,799,000 | ¥44,645,000 | ¥47,133,000 | ¥34,944,000 |
| Other Assets | ¥2,000 | ¥3,000 | ¥2,000 | ¥2,000 |
| Total Assets | ¥104,855,000 | ¥102,226,000 | ¥94,937,000 | ¥97,134,000 |
| Liabilities | – | – | – | – |
| Payables | ¥590,000 | ¥890,000 | ¥1,563,000 | ¥1,324,000 |
| Short-Term Debt | ¥26,055,000 | ¥8,950,000 | ¥17,300,000 | ¥15,150,000 |
| Tax Payable | ¥0 | ¥1,657,000 | ¥33,000 | ¥5,915,000 |
| Deferred Revenue | ¥0 | ¥1,657,000 | ¥3,924,000 | ¥12,108,000 |
| Other Curr. Liab. | ¥16,091,000 | ¥15,893,000 | ¥11,887,000 | ¥12,468,000 |
| Total Curr. Liab. | ¥43,988,000 | ¥30,135,000 | ¥35,762,000 | ¥42,054,000 |
| LT Debt | ¥12,050,000 | ¥14,350,000 | ¥5,500,000 | ¥2,950,000 |
| Deferred Rev, NC | ¥0 | -¥441,000 | -¥428,000 | -¥343,000 |
| Deferred Tax Liab, NC | ¥595,000 | ¥441,000 | ¥428,000 | ¥343,000 |
| Other NC Liab. | ¥1,380,000 | ¥1,268,000 | ¥1,262,000 | ¥1,044,000 |
| Total NC Liab. | ¥13,430,000 | ¥15,618,000 | ¥6,763,000 | ¥3,994,000 |
| Other Liabilities | ¥0 | -¥1,000 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥82,000 | ¥73,000 | ¥44,000 |
| Total Liabilities | ¥57,418,000 | ¥45,752,000 | ¥42,525,000 | ¥46,048,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥49,697,000 |
| Common Stock | ¥9,061,000 | ¥9,061,000 | ¥9,061,000 | ¥9,061,000 |
| Retained Earnings | ¥31,191,000 | ¥37,278,000 | ¥34,273,000 | ¥33,241,000 |
| AOCI | ¥1,460,000 | ¥2,416,000 | ¥1,421,000 | ¥1,184,000 |
| Other Equity | ¥5,000 | ¥2,000 | ¥0 | ¥0 |
| Total Equity | ¥47,043,000 | ¥56,178,000 | ¥52,161,000 | ¥50,881,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥392,000 | ¥297,000 | ¥251,000 | ¥205,000 |
| Total Liab. & Tot. Equity | ¥104,855,000 | ¥102,226,000 | ¥94,937,000 | ¥97,134,000 |
| Net Debt | ¥24,909,000 | ¥4,544,000 | ¥9,522,000 | -¥12,633,000 |